Cidara Therapeutics (20D0.F) Q3 2024 Earnings

13AugConfirmed
Q2 2024
Q3 2024
-18.18
-12.82
-7.45
-2.09

Details

Expected EPS
-3.7280889999999998
Actual EPS
-18.176707099999998
Surprise EPS
-14.45
Surprise Percent
+387.56%

Description

Cidara Therapeutics (20D0.F) has reported earnings of -18.176707099999998 per share for Q3 2024.

0 Comments

Share your thoughts